Safety and single-dose pharmacokinetics of abacavir (1592U89) in human immunodeficiency virus type 1-infected children. (Q33976456)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10049275%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Safety and single-dose pharmacokinetics of abacavir (1592U89) in human immunodeficiency virus type 1-infected children (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10049275%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

1 reference

W Hughes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10049275%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

J A McDowell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10049275%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

J Shenep

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10049275%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

P Flynn

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10049275%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

M W Kline

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10049275%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

R Yogev

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10049275%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

W Symonds

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10049275%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Y Lou

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10049275%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

S Hetherington

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10049275%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

language of work or name

English

0 references

publication date

1 March 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10049275%20AND%20SRC:MED&resulttype=core&format=json

Antimicrobial Agents and Chemotherapy

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10049275%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10049275%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10049275%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

609-615

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10049275%20AND%20SRC:MED&resulttype=core&format=json

Safety and pharmacokinetics of abacavir (1592U89) following oral administration of escalating single doses in human immunodeficiency virus type 1-infected adults

11 November 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89168

Epidemiology of HIV/AIDS in women and children in the USA.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89168

Unique intracellular activation of the potent anti-human immunodeficiency virus agent 1592U89

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89168

Combination of mutations in human immunodeficiency virus type 1 reverse transcriptase required for resistance to the carbocyclic nucleoside 1592U89

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89168

1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89168

In vitro antiviral activity of 141W94 (VX-478) in combination with other antiretroviral agents

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89168

Lamivudine in children with human immunodeficiency virus infection: a phase I/II study. The National Cancer Institute Pediatric Branch-Human Immunodeficiency Virus Working Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89168

Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89168

Pharmacokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infection.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89168

Clinical pharmacology of 2',3'-dideoxyinosine in human immunodeficiency virus-infected children.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89168

A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89168

A phase I/II evaluation of stavudine (d4T) in children with human immunodeficiency virus infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89168

Phase I Evaluation of Zalcitabine Administered to Human Immunodeficiency Virus-Infected Children

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89168

Antiretroviral therapy for infection due to human immunodeficiency virus in children

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10049275

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prevalence and Incidence of Vertically Acquired HIV Infection in the United States

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10049275

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The pharmacokinetics of zidovudine administered by continuous infusion in children

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10049275

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.43.3.609

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10049275%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10049275%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

PubMed publication ID

10049275

1 reference